Welcome to the Ypsomed Blog
Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.
Flying on two wings: How Ypsomed built a dual-engine strategy to lead China's drug delivery market
How can pharmaceutical companies succeed in China's evolving drug delivery market? Cui Hong, Orfeo Niedermann and Shawn James explore how Ypsomed's dual-engine strategy is making the difference.
Connected selfcare: setting a new standard
Whitepaper – How to establish clear measurable outcome metrics that align technology with therapeutic goals and couple robust data generation strategies with holistic patient experience and treatment efficacy.
Automated assembly for fast-track design verification of YpsoMate platforms
Discover how Ypsomed’s innovative in-house assembly system streamlines workflows, enhances precision and slashes verification times, helping customers bring their products to market with speed and confidence.
Advancing large-volume subcutaneous drug delivery
What are the latest trends in large-volume drug delivery? A recent study explores key developments, while Ypsomed’s innovative injection platforms address the challenges of large volumes and high viscosities with patient-friendly solutions.
CE-certified reusable pens: Immediate certification for market access
Discover how Ypsomed’s CE-certified reusable pens, ServoPen and YpsoPen, streamline market access. Our innovative platform model simplifies compliance, accelerates product availability, and provides comprehensive support to pharmaceutical partners at …
High performance in high-dose drug delivery
Discover how Ypsomed’s advanced delivery devices, including YpsoMate and YpsoDose, empower high-dose drug delivery. From viscosities to volumes, our innovative platforms transform patient care and enable pharmaceutical success. Explore the solutions …
Device-enabled digital health solutions
White paper – Discover which business opportunities digital health solutions enable for pharmaceutical companies, starting from research and development, expanding to commercialisation through pre-launch, expansion, maturity and loss of exclusivity.
Digital selfcare – Solving patient challenges while delivering business insights to pharma
Article – Discover how digital health solutions make selfcare simpler and easier for patients while also facilitating research and development, market access and commercial success for pharmaceutical companies.
First Deliveries of YpsoMate 1 mL as part of the NetZero Program
Ypsomed supplied first batches of YpsoMate 1 mL with a reduced carbon footprint as part of the NetZero Program in 2023 . This milestone is a key step in the transformation of the platform proven YpsoMate autoinjector into a zero-carbon emission …
Load more